Literature DB >> 25377911

HMGB1 exacerbates renal tubulointerstitial fibrosis through facilitating M1 macrophage phenotype at the early stage of obstructive injury.

Shaojiang Tian1, Lansing Zhang2, Junming Tang1, Xia Guo2, Kun Dong2, Shi-You Chen3.   

Abstract

Previous studies have indicated that macrophage phenotype diversity is involved in the progression of renal fibrosis. However, the factors facilitating M1 or M2 phenotypes and the function of these polarized macrophages in kidney injury and fibrosis remain largely unknown. In the present study, we found that macrophages accumulated in the kidney interstitium exhibited mainly as the M1 phenotype at the early stage of unilateral ureter obstruction (UUO). High-mobility group box 1 (HMGB1) protein expressed and released from tubular epithelial cells and interstitial macrophages was essential for the M1 macrophage transition. HMGB1 significantly induced the expression of the M1 marker inducible nitric oxide synthase while decreasing the M2 marker IL-10 in macrophages. Moreover, a glycyrrhizic acid derivative, a blocker of HMGB1 release, reduced UUO-mediated kidney injury and ameliorated UUO-induced renal fibrosis. Interestingly and importantly, UUO caused a low pH value in the urine accumulated in the obstructed ureter, and the acidified urine induced HMGB1 release from tubular epithelial cells and macrophages in vitro. Our data demonstrate that HMGB1 is an essential contributor in facilitating M1 polarization at the early stage of UUO. Inhibition of HMGB1 release may alter macrophage phenotype and contribute to the protection of kidney tissue from injury and fibrosis.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  high-mobility group box 1 protein; macrophage; phenotype; renal fibrosis; unilateral ureter obstruction

Mesh:

Substances:

Year:  2014        PMID: 25377911      PMCID: PMC4281691          DOI: 10.1152/ajprenal.00484.2014

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  24 in total

Review 1.  Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis.

Authors:  Hans-Joachim Anders; Mi Ryu
Journal:  Kidney Int       Date:  2011-08-03       Impact factor: 10.612

Review 2.  Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes also drive regeneration and fibrosis.

Authors:  Hans-Joachim Anders; Liliana Schaefer
Journal:  J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 10.121

3.  Enhanced glomerular phospholipase activity in the obstructed kidney.

Authors:  A Fukuzaki; J Morrissey; S Klahr
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

4.  Proximal tubule PPARα attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction.

Authors:  Shenyang Li; Nithya Mariappan; Judit Megyesi; Brian Shank; Krishnaswamy Kannan; Sue Theus; Peter M Price; Jeremy S Duffield; Didier Portilla
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-26

Review 5.  Potential approaches to reverse or repair renal fibrosis.

Authors:  Desiree Tampe; Michael Zeisberg
Journal:  Nat Rev Nephrol       Date:  2014-02-11       Impact factor: 28.314

6.  Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy.

Authors:  S Mizuno; K Matsumoto; T Nakamura
Journal:  Kidney Int       Date:  2001-04       Impact factor: 10.612

7.  Transforming growth factor-beta 1 antisense oligodeoxynucleotides block interstitial fibrosis in unilateral ureteral obstruction.

Authors:  Y Isaka; M Tsujie; Y Ando; H Nakamura; Y Kaneda; E Imai; M Hori
Journal:  Kidney Int       Date:  2000-11       Impact factor: 10.612

8.  Discrete functions of M2a and M2c macrophage subsets determine their relative efficacy in treating chronic kidney disease.

Authors:  Junyu Lu; Qi Cao; Dong Zheng; Yan Sun; Changqi Wang; Xiao Yu; Ya Wang; Vincent W S Lee; Guoping Zheng; Thian K Tan; Xin Wang; Stephen I Alexander; David C H Harris; Yiping Wang
Journal:  Kidney Int       Date:  2013-05-01       Impact factor: 10.612

9.  Synthesis, biological evaluation, and molecular modeling of glycyrrhizin derivatives as potent high-mobility group box-1 inhibitors with anti-heart-failure activity in vivo.

Authors:  Dan Du; Jun Yan; Jinhong Ren; Haining Lv; Yong Li; Song Xu; Yadan Wang; Shuanggang Ma; Jing Qu; Weibin Tang; Zhuowei Hu; Shishan Yu
Journal:  J Med Chem       Date:  2012-12-24       Impact factor: 7.446

10.  Protective effect of glycyrrhizin, a direct HMGB1 inhibitor, on focal cerebral ischemia/reperfusion-induced inflammation, oxidative stress, and apoptosis in rats.

Authors:  Gu Gong; Lei Xiang; Libang Yuan; Ling Hu; Wei Wu; Lin Cai; Liang Yin; Hailong Dong
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

View more
  38 in total

Review 1.  Recent progress on surfactant protein A: cellular function in lung and kidney disease development.

Authors:  Skylar D King; Shi-You Chen
Journal:  Am J Physiol Cell Physiol       Date:  2020-07-08       Impact factor: 4.249

Review 2.  Renal fibrosis: Primacy of the proximal tubule.

Authors:  Leslie S Gewin
Journal:  Matrix Biol       Date:  2018-02-06       Impact factor: 11.583

Review 3.  Inflammasomes in the urinary tract: a disease-based review.

Authors:  J Todd Purves; F Monty Hughes
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-11

4.  Probiotics ameliorate renal ischemia-reperfusion injury by modulating the phenotype of macrophages through the IL-10/GSK-3β/PTEN signaling pathway.

Authors:  Chenguang Ding; Feng Han; Heli Xiang; Yuxiang Wang; Yang Li; Jin Zheng; Wujun Xue; Xiaoming Ding; Puxun Tian
Journal:  Pflugers Arch       Date:  2018-11-13       Impact factor: 3.657

Review 5.  Macrophage Phenotype in Kidney Injury and Repair.

Authors:  Xiao-Ming Meng; Patrick Ming-Kuen Tang; Jun Li; Hui Yao Lan
Journal:  Kidney Dis (Basel)       Date:  2015-08-07

6.  FTY720 ameliorates renal fibrosis by simultaneously affecting leucocyte recruitment and TGF-β signalling in fibroblasts.

Authors:  T Tian; J Zhang; X Zhu; S Wen; D Shi; H Zhou
Journal:  Clin Exp Immunol       Date:  2017-07-27       Impact factor: 4.330

7.  The haptoglobin beta subunit sequesters HMGB1 toxicity in sterile and infectious inflammation.

Authors:  H Yang; H Wang; Y Wang; M Addorisio; J Li; M J Postiglione; S S Chavan; Y Al-Abed; D J Antoine; U Andersson; K J Tracey
Journal:  J Intern Med       Date:  2017-05-31       Impact factor: 8.989

Review 8.  Macrophage polarization and allergic asthma.

Authors:  Arjun Saradna; Danh C Do; Shruthi Kumar; Qing-Ling Fu; Peisong Gao
Journal:  Transl Res       Date:  2017-10-07       Impact factor: 7.012

9.  C1q and HMGB1 reciprocally regulate human macrophage polarization.

Authors:  Myoungsun Son; Amit Porat; Mingzhu He; Jolien Suurmond; Frances Santiago-Schwarz; Ulf Andersson; Thomas R Coleman; Bruce T Volpe; Kevin J Tracey; Yousef Al-Abed; Betty Diamond
Journal:  Blood       Date:  2016-09-28       Impact factor: 22.113

Review 10.  Collectins in urinary tract and kidney diseases.

Authors:  Yongfang Qin; Jingjing Liu; Jiao Liu; Fengqi Hu
Journal:  Int Urol Nephrol       Date:  2017-10-25       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.